Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-05-12
2010-02-09
Kolker, Daniel E. (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07659255
ABSTRACT:
The present invention relates to a method of using biologically active peptide compounds comprising the tri-peptide motif KDI derived from the neurite outgrowth-promoting domain of laminin-1 as inhibitors of ionotropic glutamate receptors. The peptide compounds are therefore useful in methods of treating disorders responsive to the blockade of these receptors, such as Alzheimer's disease, Parkinson's disease, ALS or stroke.
REFERENCES:
patent: 5721256 (1998-02-01), Hamilton et al.
patent: 5780090 (1998-07-01), Frero et al.
patent: 200 10 297 (2000-10-01), None
patent: 0 067 425 (1982-12-01), None
patent: 2 284 422 (1995-06-01), None
patent: WO 93/24155 (1993-12-01), None
patent: WO 94/04560 (1994-03-01), None
patent: WO 98/43686 (1998-10-01), None
patent: WO 98/45325 (1998-10-01), None
patent: WO 99/00418 (1999-01-01), None
patent: WO 01/66164 (2001-09-01), None
Milman et al (1980). Acta Derma Venerol. 60, 85-87. (abstract only).
Carney (2005). Drug Discovery Today. 10, 1268.
Nagaratnam et al (2002). Journal of Clinical Neuroscience. 9, 473-476.
Hanafiah et al (1989). Journal of the royal society of Medicine. 84,48-49.
Miura et al (2000). Experimental Neurology. 166, 115-126.
Kawamata et al (1997). PNAS. 94, 8179-8184.
Rogeji et al (1989). JCB. 109, 823-.
Mercadante et al (1998). Jouranl of Pain and Symptoms Management. 16, 317-322.
Sun et al (1993). Neuroreport. 4, 1147-1150 (abstract only).
Hoyte et al (2004). Current Molecular Medicine. 4, 131-136.
Mercandante et al. (1998) Journal of Pain and Symptom Management. 16, 317-322.
Widdowson et al. (1996). Brain Research. 738, 236-242.
Tsushida et al. (1997). J. Neurotrauma. 409-417. Abstract only.
Hoyte et al. (2004). Current Molecular Medicine. 4, 131-136. Abstract only.
Eric Guadagno et al., GLIA 47: pp. 138-149 (2004).
Ron Liebkind et al., Journal of Neuroscience Research 73: pp. 637-643 (2003).
Päivi Liesi et al., FEB 06825, vol. 244, No. 1, 141-148, Feb. 1989.
P. Liesi, Experientia 46 (1990).
Päivi Liesi et al., Journal of Neuroscience Research 64: pp. 144-167 (2001).
Päivi Liesi et al, Journal of Neuroscience Research 66: pp. 1047-1053 (2001).
Päivi Liesi et al., Experimental Neurology 173, pp. 31-45 (2002).
S. Murtomaki et al., Journal of Neuroscience Research 32: pp. 261-273 (1992).
Hiroshi Nishimune et al., Nature Publishing Group vol. 432, pp. 580-587, Dec. 2, 2004.
Edouard Palu et al., Journal of Neuroscience Research 69: 243-256 (2002).
Arja Pasternack et al., The Journal of Biological Chemistry, vol. 277, No. 51, pp. 49662-49667, Dec. 20, 2002.
Markus Wiksten et al., Journal of Neuroscience Research 71: pp. 338-352 (2003).
Markus Wiksten et al., Journal of Neuroscience Research 78: pp. 403-410 (2004).
Markus Wiksten et al., Journal of Neuroscience Research 78: pp. 411-419(2004).
T. Serafini et al., Cell. Aug. 12, 1994: 78(3):409-24; PubMed Abstract ID:8062384.
P. Liesi et al., Journal of Neuroscience Research, 40:199-206 (1995).
M. Matsuzawa et al., Int. J. Devl. Neuroscience, vol. 14, No. 3, pp. 283-295, 1996.
M. Matsuzawa et al., Journal of Neuroscience Research, 53:114-124 (1998).
J. Meyerhardt et al., Cell Growth & Differentiation, vol. 10, 35-42, Jan. 1999.
Birch & Stewart Kolasch & Birch, LLP
Kolker Daniel E.
LandOfFree
Methods of inhibiting glutamate receptors by administering... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting glutamate receptors by administering..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting glutamate receptors by administering... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4182596